This inventor holds 6 USPTO granted patents and 12 published patent applications and 2 EPO patents. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2025
Title: Rida Mourtada: Innovator in Antimicrobial Peptides
Introduction
Rida Mourtada is a prominent inventor based in Brookline, MA, known for his significant contributions to the field of antimicrobial peptides. With a total of six patents to his name, Mourtada has made strides in developing innovative solutions to combat infections.
Latest Patents
Among his latest patents is a groundbreaking invention involving stapled intracellular-targeting antimicrobial peptides designed to treat infections. These structurally stabilized peptides possess the unique ability to translocate through microbial cell membranes, allowing them to exert biological activity within microbial cells. Additionally, Mourtada has developed a system for visually representing peptide sequences. This system includes a memory configured to store instructions and a processor that executes these instructions to perform various operations, such as categorizing amino acids and producing visual representations of filtered relationship groups.
Career Highlights
Mourtada's career is marked by his work at the Dana-Farber Cancer Institute, where he has been instrumental in advancing research in the field of cancer treatment. His innovative approaches have garnered attention and respect within the scientific community.
Collaborations
Mourtada has collaborated with notable colleagues, including Loren D. Walensky and Henry D. Herce, further enhancing the impact of his research and inventions.
Conclusion
Rida Mourtada's contributions to the field of antimicrobial peptides and his innovative patents reflect his dedication to advancing medical science. His work continues to pave the way for new treatments and solutions in combating infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
